Are pharmaceutical companies allowed to provide financial assistance for travel, lodging and other expenses to certain patients? Join FDA regulatory attorney Darshan Kulkarni as he discusses why the Office of Inspector General (OIG) decided in favor of financially helping patients, and what the implications of this decision may be.
A discussion with CRO CEO John Reites. Our discussion will explore decentralized clinical trials, the missing secret ingredient in clinical...
A discussion with health and clinical trial entrepreneur Zedrick Buhay on starting a clinical trial site, choosing studies and therapeutic...
A discussion on Project Management/Clinical Monitoring/Clinical Operations including on Clinical Development Training, recruitment and...
